Azithromycin (T1225)

DRUG4 trials

Sponsors

Laboratoires Thea

Conditions

Conjunctivitis, BacterialEye Infections, Bacterial

Phase 1

Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers

CompletedNCT00357383

Laboratoires TheaEye Infections, Bacterial

Start: 2002-10-31End: 2002-10-31Updated: 2006-07-27

Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers

CompletedNCT00357292

Laboratoires TheaEye Infections, Bacterial

Start: 2002-03-31End: 2002-04-30Updated: 2006-07-27

Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers

CompletedNCT00357539

Laboratoires TheaEye Infections, Bacterial

Start: 2002-02-28End: 2002-03-31Updated: 2006-07-27

Phase 3

Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis

CompletedNCT00357773

Laboratoires TheaConjunctivitis, Bacterial

Start: 2004-05-31End: 2005-06-30Updated: 2006-07-27